A Leading Location
The German capital region provides outstanding potential for development and ideal conditions for the biotechnology and pharmaceuticals industry. Its major strengths are a unique research landscape and a close network of the players along the entire value-added chain. Its many technology parks and networks in various fields of modern biotechnology provide an excellent infrastructure and form the technological backbone of the biotechnology and pharmaceuticals industry in Berlin and Brandenburg.
Are you planning on developing your company’s presence in the German capital? A good choice! We will help you implement your decision to locate or expand your company in Berlin-Brandenburg.
Berlin, Germany, and Toronto, Canada, MAY 24, 2016: SCIENION AG, a developer of a revolutionary new ultra-low volume liquid handling technology, is pleased to announce that it has entered into a strategic, joint development...
ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics
Afucosylation can enable more precise assessment of allergic sensitization
Humedics submits marketing authorization application for the diagnostic agent used with the LiMAx test
Application for marketing authorization of the diagnostic agent 13C-Methacetin Solution for infusion used with the LiMAx test
Meet the German Capital Region at BIO in San Francisco | June 06-09 | German Pavilion | Booth 905-09
Entrance Markgrafenstraße 38
Nils Ericsons Plan 4
The largest Nordic partnering conference for the global Life Science industry / HealthCapital Berlin-Brandenburg is acting as conference supporter / Early Bird rates apply!